Skip to content
Disclosery

EXANE DERIVATIVES: AMT position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on AMT, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 1,646 AMT shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 1,646 shares
    Change vs previous 13F -375 shares

    0.24% of the 13F portfolio, value $420,657.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 2,021 shares
    Change vs previous 13F -412 shares

    0.14% of the 13F portfolio, value $507,719.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 2,433 shares
    Change vs previous 13F -396 shares

    0.17% of the 13F portfolio, value $711,675.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 2,829 shares
    Change vs previous 13F +887 shares

    0.19% of the 13F portfolio, value $750,875.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 1,942 shares
    Change vs previous 13F +1,646 shares

    0.13% of the 13F portfolio, value $540,917.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 296 shares
    Change vs previous 13F -514 shares

    0.02% of the 13F portfolio, value $70,765.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 810 shares
    Change vs previous 13F +603 shares

    0.06% of the 13F portfolio, value $181,821.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 207 shares
    Change vs previous 13F not available

    0.02% of the 13F portfolio, value $50,039.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).